Images are for illustrative purposes only.
Glow
Glow 70 mg is a three-component research blend supplied as a single lyophilized preparation. Each vial contains 70 mg of total peptide, made up of 10 mg BPC-157, 10 mg TB-500, and 50 mg GHK-Cu. The 70 mg figure is the combined mass of all three peptides in the vial, not the amount of any single component.
It is formulated for combination studies where angiogenic, cytoskeletal, and copper-dependent matrix pathways are examined together rather than in isolation. In vitro research focuses on extracellular-matrix and collagen-synthesis signaling, driven largely by the GHK-Cu component, which is why that peptide carries the largest share of the blend, along with angiogenesis and actin regulation from BPC-157 and TB-500, and antioxidant response.
Glow is the lighter counterpart to Klow: it centers on collagen and skin/matrix pathways, whereas Klow adds KPV for an additional anti-inflammatory emphasis. Supplied as a lyophilized 10-vial kit at 70 mg per vial (700 mg total peptide) for in vitro research use only.